Applications
Imaging that resolves what other methods miss.
Panluminate's pan-ExM platform delivers nanoscale, multiplexed views of tissue architecture across therapeutic areas—from neurodegeneration to oncology to rare disease. We work with pharmaceutical partners, biotechs, and academic groups to translate sample to insight.
Imaging
Drug programs fail when targets, mechanisms, and tissue context aren't fully understood before the clinic. Panluminate's imaging services give discovery teams nanoscale views of native tissue-proteins, organelles, and cellular architecture resolved together in a single sample, without the throughput limits of EM or the labeling constraints of super-resolution.
CNS
Oncology
Immunology
Rare Disease
Infrastructure
Today, Panluminate's pan-ExM platform is the imaging and data infrastructure powering some of the field's most ambitious connectomics efforts — partnering with research groups and consortia working toward the world's reference connectome.
Learn More
Learn More
